Rentokil Initial PLC ADR (RTO)

Rentokil Initial plc is a United Kingdom-based provider of route-based commercial services operating across North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and the Pacific. Its business activities include pest control for rodents, flying and crawling insects, and other wildlife management services, alongside hygiene solutions such as dispensers for soap, hand sanitizer, air care, purification, and restroom-related products. The company also supplies and launders garments for commercial clients and provides specialist cleaning services, including graffiti removal, deep cleaning for kitchens and washrooms, trauma cleaning, and cleanup following flood or fire damage. This listing is an ADR, or depositary receipt, tied to Rentokil Initial plc’s common stock. Founded in 1903, the company is headquartered in Crawley, United Kingdom.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-RTO
$29.51
29.6% Upside
Undervalued
$30.70
34.8% Upside
Undervalued
Fair
2.4%
November 6, 2026
35.4x
2.1x
1.6x
11.407 B
14.977 B
35.1%
98.2%
8.9
65.7%
238.8%
Valuation • Fair Value

Rentokil Initial PLC ADR (NYSE-RTO) Fair Value by Valuation Model

Review the available estimates for Rentokil Initial PLC ADR (NYSE-RTO), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$29.51

Estimated upside of 29.6% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$33.54

Discounted cash flow valuation reference.

Ben Graham Formula Value

$7.23

Classic Ben Graham valuation formula reference.

DDM Fair Value

$25.43

Dividend discount model valuation reference.

Comps Fair Value

$26.83

Comparable-company valuation reference.

Analyst Price Target

$30.70

Analysts imply upside of 34.8%.

How to read these valuation models

Use the 7 available valuation references for Rentokil Initial PLC ADR (NYSE-RTO) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Rentokil Initial PLC ADR (NYSE-RTO)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

7.133 B

Current operating scale indicator.

Revenue Forecast

7.25 B

Forward revenue estimate.

EBITDA

1.252 B

Current operating profitability reference.

EBITDA Forecast

1.525 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Rentokil Initial PLC ADR (NYSE-RTO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Rentokil Initial PLC ADR (NYSE-RTO)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.65

No elevated caution signal from this screen.

Altman Z-Score

8.9

Relatively strong balance-sheet zone.

FCF / Net Income

238.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Rentokil Initial PLC ADR (NYSE-RTO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Rentokil Initial PLC ADR (NYSE-RTO)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 6, 2026

Days to Earnings

13

Dividend Yield

2.4%

Current income yield reference.

Payout Ratio

65.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Rentokil Initial PLC ADR (NYSE-RTO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Rentokil Initial PLC ADR (NYSE-RTO) Stock Forecast & Technical Outlook

Review Rentokil Initial PLC ADR (NYSE-RTO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Rentokil Initial PLC ADR (NYSE-RTO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Rentokil Initial PLC ADR (NYSE-RTO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Rentokil Initial PLC ADR (NYSE-RTO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Rentokil Initial PLC ADR (NYSE-RTO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Rentokil Initial PLC ADR (NYSE-RTO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Rentokil Initial PLC ADR (NYSE-RTO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Rentokil Initial PLC ADR (NYSE-RTO) has a Buy consensus, with 2 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 1
Sell 0
FAQ • Fast Investor Answers

Rentokil Initial PLC ADR (NYSE-RTO) Stock FAQ

Data-supported answers about Rentokil Initial PLC ADR (NYSE-RTO), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$29.51
Estimated upside 29.6%
Valuation Rating
Undervalued
Estimated upside of 29.6%
Analyst Target
$30.70
Implied upside 34.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Rentokil Initial PLC ADR (NYSE-RTO) is $29.51. This implies an estimated upside of 29.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 29.6% versus the current market price.

The available analyst price target for Rentokil Initial PLC ADR (NYSE-RTO) is $30.70. The analyst target implies estimated upside of 34.8%.

The current financial health read for Rentokil Initial PLC ADR (NYSE-RTO) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Rentokil Initial PLC ADR (NYSE-RTO) is November 6, 2026.

Based on the current data, dividend yield is 2.4%.

The current P/E ratio listed for Rentokil Initial PLC ADR (NYSE-RTO) is 35.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Rentokil Initial PLC ADR is 11.407 B.

The current enterprise value listed for Rentokil Initial PLC ADR is 14.977 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Rentokil Initial PLC ADR is NYSE-RTO, and the stock is listed on NYSE.

Rentokil Initial PLC ADR (NYSE-RTO) is listed on NYSE.

The current debt-to-total-capital ratio listed for Rentokil Initial PLC ADR is 35.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Rentokil Initial PLC ADR is 98.2%. Free float helps investors understand how much of the share base is available for public trading.